English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Celgene Corporation
+
Community
Karen Kidd
| Oct 23, 2018
Think tank founder recommends standard patents over intellectual property rights to cut drug prices
+
Technology/Innovation
Carrice Quinnie
| Jun 2, 2017
Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
+
Technology/Innovation
LocalLabs News Service
| Apr 10, 2017
Oral medication reduced psoriasis symptoms, study says
+
Regulatory
Gene Johnson
| Mar 10, 2017
FDA accepts Celgene Corp.'s application for leukemia treatment drug
+
Technology/Innovation
Amanda Rupp
| Aug 19, 2016
Torres, Celgene partner for psoriasis campaign
+
Community
Amanda Rupp
| Jun 1, 2016
World MS Day research to increase independence of MS patients
+
Technology/Innovation
Amanda Rupp
| May 16, 2016
Acute myeloid leukemia persists as major health problem
+
Technology/Innovation
Amanda Rupp
| Apr 14, 2016
WHO calls for better accessibility to psoriasis treatments
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
